Changes of the vaginal microbiota in HPV infection and cervical intraepithelial neoplasia: a cross-sectional analysis

Sci Rep. 2022 Feb 18;12(1):2812. doi: 10.1038/s41598-022-06731-5.

Abstract

This study aimed to explore the changes of the vaginal microbiota and enzymes in the women with high-risk human papillomavirus (HR-HPV) infection and cervical lesions. A total of 448 participants were carried out HPV genotyping, cytology tests, and microecology tests, and 28 participants were treated as sub-samples, in which vaginal samples were characterized by sequencing the bacterial 16S V4 ribosomal RNA (rRNA) gene region. The study found the prevalence of HR-HPV was higher in patients with BV (P = 0.036). The HR-HPV infection rate was 72.73% in G. vaginalis women, which was significantly higher than that of women with lactobacillus as the dominant microbiota (44.72%) (P = 0.04). The positive rate of sialidase (SNA) was higher in women with HR-HPV infection (P = 0.004) and women diagnosed with cervical intraepithelial neoplasia (CIN) (P = 0.041). In HPV (+) women, the α-diversity was significantly higher than that in HPV (-) women. The 16S rRNA gene-based amplicon sequencing results showed that Lactobacillus was the dominant bacteria in the normal vaginal microbiota. However, the proportion of Gardnerella and Prevotella were markedly increased in HPV (+) patients. Gardnerella and Prevotella are the most high-risk combination for the development of HPV (+) women. The SNA secreted by Gardnerella and Prevotella may play a significant role in HPV infection progress to cervical lesions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alphapapillomavirus / genetics
  • Alphapapillomavirus / pathogenicity
  • Bacteria / classification
  • Bacteria / genetics
  • Female
  • Humans
  • Lactobacillus / genetics
  • Microbiota / genetics*
  • Neuraminidase / genetics
  • Papillomavirus Infections / genetics
  • Papillomavirus Infections / microbiology*
  • Papillomavirus Infections / pathology
  • Papillomavirus Infections / virology
  • RNA, Ribosomal, 16S / genetics
  • Uterine Cervical Dysplasia / genetics
  • Uterine Cervical Dysplasia / microbiology*
  • Uterine Cervical Dysplasia / pathology
  • Uterine Cervical Dysplasia / virology
  • Vagina / microbiology*
  • Vagina / virology

Substances

  • RNA, Ribosomal, 16S
  • Neuraminidase